Schwann cells (SC) enter the central nervous system (CNS) in pathophysiological conditions. However, how SC invade the CNS to remyelinate central axons remains undetermined. We studied SC migratory behavior ex vivo and in vivo after exogenous transplantation in the demyelinated spinal cord. Data highlight for the first time that SC migrate preferentially along blood vessel in perivascular extracellular matrix (ECM), avoiding CNS myelin. We demonstrate in vitro and in vivo that this migration route occurs by virtue of a dual mode of action of Eph/ephrin receptor. Indeed, EphrinB3, enriched in myelin, interacts with SC Eph receptors, to drive SC away from CNS myelin, and triggers their preferential adhesion to ECM components, such as fibronectin via integrinβ1 interactions. This complex interplay enhances SC migration along the blood vessel network and together with lesion-induced vascular remodeling facilitates their timely invasion of the lesion site. These novel findings elucidate the mechanism by which SC invade and contribute to spinal cord repair.
INTRODUCTION
Myelination, the evolutionary characteristic acquired by vertebrates to allow rapid and saltatory nerve conduction, is supported by two different glial cell types, oligodendrocytes in the central nervous system (CNS), and Schwann cells (SC) in the peripheral nervous system (PNS). These two cell types are mutually exclusive in physiological conditions. However, in demyelinating diseases or injury, this PNS/CNS segregation is compromised and both, SC can invade and repair the CNS (1, 2) , and oligodendrocytes myelinate peripheral nerve root axons (3) . Remyelination of CNS axons by SC protects axons, restores axonal conduction and even reverses neurological deficits (4) , highlighting their potential to rescue the injured CNS (5) .
These remyelinating SC arise either from the PNS (6, 7) , or are generated from adult oligodendrocyte precursors cells (OPC) (8, 9) . However, SC remyelination of CNS axons is always restricted to the spinal roots entry and exit zones (reviewed in (5) ), and the presence of peripheral myelin has been frequently observed close to blood vessels (BV) (1) . These observations suggest that although SC migrate efficiently in vitro (10, 11) and in vivo (12) into the PNS, their survival and migration within the CNS are limited. The presence of peripheral myelin close to BV raises the possibility for BV to play a role in guiding SC movements within the CNS. While migration along BV has been recently described for different CNS cell types (13) (14) (15) including for SC along regenerative nerves (12) , their role in SC invasion of the CNS has not been explored.
Astrocytes (16, 17) and CNS white matter (18) (19) (20) inhibit SC migration within CNS, pointing out that multiple CNS components can alter this process. Among the molecules involved in various cell type segregation and guidance within the CNS, the Eph/ephrin family has been implicated in both developmental (21, 22) and 4 pathological conditions (23) . In particular, EphrinB3, is expressed in myelin in brain and mouse spinal cord (24) (25) (26) , and plays an important role in preventing neurite outgrowth (24) , axonal regeneration (25) and oligodendrocyte progenitor differentiation (26) . EphrinB3 acts also as a repellent molecule in the guidance of axon tracts towards the spinal cord during development (27) . Interestingly, SC express several Ephrin receptors, including EphA4 that mediates SC repulsion by astrocyte EphrinAs (28) . Hence, these receptors could mediate also similar SC repulsion by myelin-associated EphrinB3. In addition, EphB is involved in SC sorting and migration in regenerating peripheral nerves (29) . Eph/ephrin signalling is involved in the modulation of cell-cell adhesion, which results in increased integrin-mediated adhesion of Eph/ephrin-expressing cells (30, 31) or, as in the case of EphB signaling, in cell sorting by re-localization of N-cadherin in SC (29) . Furthermore, EphrinB ligands control cell migration through positive adhesion to substrates such as collagen and fibronectin (FN) (32, 33) , main components of perivascular extracellular matrix (ECM). Therefore, these cues could influence the capacity of SC to migrate within the CNS and/or interact with CNS myelin.
In spite of these observations, a role for BV in SC migration/recruitment in the CNS and for EphrinB3 in modulating SC interactions with CNS myelin and/or BV has not been investigated. Using ex vivo, in vivo and in vitro paradigms, we show that BV are a preferred substrate for SC migration into the CNS, and that, angiogenesis and BV remodeling constitute a physiological response to demyelination. Moreover, we establish that CNS myelin plays an essential role in SC exclusion from the CNS and demonstrate that this effect is partially mediated by EphrinB3. Finally, myelinassociated EphrinB3 modulates SC adhesion to the ECM component FN, via
interactions with integrinβ1. This increased SC-FN adhesion, to perivascular ECM 5 overrules SC inhibition by myelin and promotes SC migration along BV, facilitating their arrival at the lesion. Thus Eph/ephrin may guide SC within the CNS according to a dual mode, repulsing SC from CNS white matter on one hand, and favoring their interaction with BV on the other. These observations shed new light on the mechanism of SC invasion into the damaged CNS. 6 
RESULTS

Schwann cells preferential migration along blood vessels by passes their inhibition by myelin
To address this question, we analysed the SC interactions with CNS components, myelin and blood vessels, in ex vivo and in vivo paradigms (Fig. 1, Fig. S1 and Fig.   S2 ). For ex-vivo analysis, GFP-expressing SC (GFP + ) were seeded on frozen spinal cord sections. We found that GFP + SC adhered 11.88 fold more over grey matter (0.32±0.05% of total area) than white matter (3.8±0.2% of total area) ( Fig S1A, C) .
Moreover, SC spreading over white matter was reduced compared to grey matter (GFP + SC area per Hoechst + in GM: 230.0±8.5 μm 2 /cell; in WM: 172.3±11.91 μm 2 /cell) ( Fig. S1D ). Immunolabeling for Glut1 showed that BV were 7.78 fold more abundant in grey matter than white matter (Glut1 + area in GM: 40.9±8.2% of total area; in WM: 5.2±1.6% of total area) ( Fig. S1B ,E) and that most GFP + SC (>86%)
were in contact with collagen 4-positive BV (Fig. S1F ), indicating that SC densities in grey and white matter were correlated with BV densities in these regions.
To explore how endogenous SC invade the CNS in response to demyelination, we used the Krox20Cre driver line crossed over Rosa-YFP to track the SC lineage (3, 34) . Krox20 transcription factor is specific of the PNS, and is expressed in the SC lineage until adulthood. LPC injections were performed in the dorsal funiculus of adult mice (2-3month-old), and mice were sacrificed at 3 days post injection (dpi). YFP + SC were detected only in the spinal cord cross sections of demyelinated mice (Fig.   S2A ,B) but not in controls ( Fig S2C,D) . YFP+ cells were Sox10 + (Fig. S2E ,F) but never Olig2+ ( Fig S2G) validating their PNS glial origin. We next examined the location of the invading SC-derived population and found that at this early time-point, 7 the YFP +/ Sox10 + SC within white mater were found exclusively on Glut1 + BV. This indicates that such as observed ex-vivo, endogenous SC preferentially associate with BV when triggered to invade the demyelinating CNS. Although in normal development Krox20 specifically labels the peripheral SC lineage, under pathological conditions Krox20 was also expressed by Iba1+ microglial cells ( Fig.S2H,I) .
As the Krox20Cre system was limited in tracing a sufficient number of SC invading the CNS from the periphery, we pursued our investigation using an exogenous paradigm in which GFP + SC were grafted two vertebrates away from a lysolecithin (LPC) lesion in the dorsal funiculus of adult wild-type mice ( Fig 1A) . In this paradigm, grafted SC are known to be recruited specifically by the lesion, modeling SC recruitment after CNS injury, whereas they remain at the graft site in the absence of a lesion (20, 35) . As our study focused essentially on SC migration/recruitment, grafted animals were sacrificed at early time-points including 1, 3 and 5-day post-LPC injection (dpi) (Fig. 1B) . The spatio-temporal distribution of the transplanted GFPexpressing SC was assessed by scanning longitudinal frozen sections of the spinal cord for the GFP signal throughout the sections (20) . At 1 dpi, lesion size (0.40 ± 0.06 mm 2 per section) and GFP + SC grafted area (0.16 ± 0.08 mm 2 per section) showed minor variability among animals validating the lesion-graft paradigm. Analysis of the GFP signal over time confirmed the spatio-temporal progression of SC towards the lesion, which was systematically reached at 5 dpi ( Fig. 1B,C ).
In the intermediate zone connecting the graft to the lesion, GFP + SC migrated preferentially along the midline avoiding myelin (Fig. 1C ,D), as previously described after engraftment in shiverer and nude mice (20, 35) . In this area, SC were found preferentially in association with Glut1 + BV forming a narrow stream of cells ( Fig.   1C2 ,D). At their arrival in the lesion, GFP + SC were no longer confined to that narrow 8 path, but randomly spread within the lesion. Co-detection of GFP and Glut1 at the lesion showed that the pattern of GFP + SC matched with that of Glut1 + BV (Fig. 1C3 ).
Co-labeling for Glut1 and GFAP showed that GFP + SC were localized in perivascular spaces between endothelial cells and astrocyte end-feet ( Fig. 1E ). SC within the BV lumen were never observed.
We used whole-mount immuno-labeling of clarified spinal cords to gain insight in SC-BV3D spatial organization. For these experiments, tdTomato + SC were grafted remotely from the lesion as above, and their migratory behavior analyzed at 5 dpi. BV and SC were visualized by immuno-labeling against anti-IgG and anti-Tomato respectively. Light sheet imaging and 3D reconstruction revealed the dense spinal cord vascular network and confirmed that grafted SC, en route towards the lesion, were preferentially associated with BV in the spinal cord midline ( Fig. 1F ). TdTomato + SC were either polarized along blood vessels ( Fig. 1G ,H,I) or extending processes from one vessel to another ( Fig. 1J ,K,L).
Whether SC moved along blood vessels was further confirmed by GFP + SC live- To elucidate whether SC migrate in vivo in association with peri-vascular ECM, and/or whether they require direct interactions with endothelial cells, we performed immuno-electron microscopy (EM) on a novel series of GFP + SC grafted mice ( Fig.   1M ,N,O). EM analysis of DAB labeled GFP + SC confirmed their location in close contact with BV. Interestingly, the majority of the grafted SC was embedded within the peri-vascular ECM (Fig. 1M ,N) between the vascular cells and astrocyte end-feet ( Fig. 1O ). However, unlike observed in the injured PNS (12) , direct contact with vascular cells was never observed.
Temporal analysis of SC arrival at the lesion indicated that in lesions which had cells at early stages (3dpi), 62±9% of GFP + SC were closely associated with BV ( Fig.   2A ,C,G), while at later times (5dpi) only 32±5% of them were associated with BV ( Fig. 2B ,D,G). Immunohistochemistry for Glut1 and NF200 indicated that this transition correlated with a change in SC-BV to SC-Axon associations, with only 35±6% of GFP + SC associated with axons at 3dpi ( Fig.2A ,E,H), and 61±5% GFP + SC associated with axons at 5 days ( Fig. 2B ,F,H).
LPC induced demyelination promotes angiogenesis and blood vessel
remodeling.
Since angiogenesis has been described in demyelinating diseases (36) and perivascular niche plays a role in remyelination(9), we examined the dynamics of BV in the absence of SC grafting. We found an increase in BV density in lesions of non- 2.9±4 (p=0.001))( Fig 
Myelin-associated EphrinB3 as candidate to guide Schwann cells in the CNS.
Since no effect of exogenous SC on vascularization was observed, we hypothesized that SC guidance within the CNS by SC-BV association and myelin repulsion could be due to some receptor-ligand mediated mechanism. We previously demonstrated that SC are repulsed by CNS myelin, partially mediated by the axonal repellent MAG, suggesting that other myelin components might be involved in this repulsion (20) .
Thus, we speculated that other axonal growth inhibitors were able to induce the same effect in SC. Of interest, EphrinB3 is expressed by CNS myelin and inhibits axonal growth and oligodendrocyte differentiation (25, 26) , and SC express several Eph receptors (28) . Interestingly, immature stages of the SC lineage such as boundary cap cells and SC precursors, have a greater capacity to migrate through white matter compared to more mature SC stages (37, 38) present lower expression of another EphrinB3 receptor, the EphB6 (39) . In support of these data, we performed gene profiling by RNA sequencing, comparing aged-matched wild-type and developmentally arrested SC lacking Krox20 (Krox20 null SC)(40)(considered at a more immature-like stage) revealed a dysregulation in the transcript levels of a variety of molecules among which Eph receptors were particularly expressed at lower level. While EphA4, EphB1, EphB2, EphB3, EphB4 and EphB6 transcripts were expressed in wild-type SC, EphA4, EphB1 and EphB6 were significantly downregulated in Krox20 null SC ( Fig. S7 ). Hence, we hypothesized that EphA4, EphB6, and EphB1 could be involved in SC poor mingling with CNS white matter, and favorable association with BV.
The EphrinB3 present in myelin is able to bind and activate EphrinB3-receptors in Schwann cells.
We first confirmed that SC have the molecular machinery to bind myelin-associated
EphrinB3. Immunohistochemistry showed that purified mouse SC can bind EphrinB3
in vitro, and that these cells express the three EphrinB3 receptors: EphB6 ( Fig. 4A ), EphA4 ( Fig. 4C ) and EphB1 (Fig. 4D ). The presence of each receptor was corroborated by Western blot (Fig. 4B ). Incubation of SC with pre-clustered EphrinB3 by fluorescent anti-Ig and orthogonal views revealed that the three receptors were able to bind clustered EphrinB3 on SC surface leading to the formation of large signaling clusters as previously described(41) ( Fig. 4A ,C,D).
Eph receptors are activated by auto-phosphorylation of specific tyrosine residues (42) .
To verify the ability of EphrinB3 to induce forward signaling, activation of Eph 12 receptors on SC was assessed. Immunocytochemistry illustrates binding of EphA4 with clustered EphrinB3, and its activation by the ligand (Fig. 4E ). EphB6 is a recognized Kinase-defective receptor, which can form a hetero-receptor complex with EphB1 receptor and undergoes trans-phosphorylation (43) . Immunohistochemistry validated the presence of phospho-Y594 in EphB1 (and EphB2) receptor, and its interaction with bound EphrinB3 in SC ( Fig. 4F ).
To test the hypothesis that myelin associated EphrinB3 is able to induce the activation of EphB and EphA4 receptors, we incubated purified SC during 30min with myelin protein extracts or myelin protein extract previously incubated with anti-EphrinB3 known to block specifically its activity (26) . SC were collected and blotted with an antibody against the phosphorylated EphA4 ( Hence, these observations evidenced the ability of SC to bind and respond to the presence of EphrinB3 in vitro.
CNS myelin inhibits Schwann cell adhesion and spreading, and this effect is partly mediated by EphrinB3 through EphA4 and EphB6 receptors.
Next, we examined whether EphrinB3 could contribute to SC-myelin repulsion. We performed a blocking receptor assay, pre-incubating purified GFP + SC with unclustered EphrinB3-Fc molecules before seeding them for 3 hours onto myelin protein extract or PBS (Fig.5A ), and evaluated both SC adherence and polarization ( Fig.5B ). Control Fc-preincubated SC showed less adhesion to myelin, measured as the ratio of adhered SC to myelin compared to PBS coated surfaces. SC also extended fewer processes, based on a higher ratio of round cells over the total adhered SC on myelin compared to control. Blocking EphrinB3 receptors on SC by soluble EphrinB3-Fc hindered myelin repulsion, resulting in a significant improvement of SC adhesion to myelin-coated surfaces, and ability to extend more processes EphrinB3: 1.5±0.5). (Fig.5A,B ).
To determine if the reduction in the number of SC adhering to myelin was due to cell death, we assessed cell viability comparing the percentage of caspase3 + nuclei or Hoechst + pycnotic nucleiin SC incubated with PBS or myelin for 3h. SC exhibited a typical bipolar morphology and no difference in the percentage of caspase3 + nuclei or Hoechst pycnotic nuclei between control and myelin-treated groups were observed (PBS: 4.4±1.6‰, Myelin: 4.0±1.7‰, n=6). These data corroborate our previous results demonstrating that short incubation time with myelin does not induce apoptosis (20) .
SC adhesion to surfaces coated with EphrinB3-Fc was reduced compared to Fc as control in a dose-dependent manner (Ratio of adhered cells EphrinB3/Fc; 2.5µg/mL: 0.9±0.3, 10µg/mL: 0.7±0.07 and 20µg/mL: 0.5±0.2. Ratio of round cells EphrinB3/Fc: 14 2.5µg/mL: 1.2±0.4, 10µg/mL: 1.8±0.4 and 20ug/mL: 3±0.9)( Fig. 5C ). Moreover, the increased number of round SC indicated that SC were less polarized on EphrinB3 coated surfaces compared to control (significance reached with high concentrations of EphrinB3) ( Fig. 5C ).
EphrinB3 behaves as a dependence receptor, which can trigger cell apoptosis (44) .
To analyze the potential effect of EphrinB3 on Schwann cell survival, we assayed cell EphrinB3/Fc:anti-EphA4 + anti-EphB6: 0.8±0.3(n=10), p(IgG vs anti-EphA4 + anti-EphB6)=0.008) two-tailed t-student test).
EphrinB3 increases Schwann cell adhesion and migration on the perivascular ECM component, fibronectin, via integrin ß1
Eph/ephrin can modulate cellular pathways by regulating cell adhesion, either positively or negatively, depending upon the cellular context (45) . Thus, positive regulation of SC adhesion to ECM and FN might have consequences on their migration capacity on this substrate (32, 33) . As our in vivo study indicated that the grafted SC were embedded in perivascular ECM, and angiogenesis is a response to demyelination, we studied the effect of EphrinB3 on SC-ECM binding, in particular The main FN-binding receptor on SC is the integrin heterodimer α5β1 (46) , and the integrin family is involved in the Eph/ephrin response (31, 32) . To question whether integrinß1 could mediate the mechanism by which EphrinB3 regulates SC-FN binding, we performed an integrinβ1 interfering assay prior to SC adhesion on substrate, compared to Fc+FN control (Fig. 7E ). This increased speed was counteracted when SC were pre-incubated with anti-EphA4 compared to control IgG.
Moreover, data confirmed that pre-incubation with IgG or anti-EphA4 did not impair SC speed or pattern of migration on FN whether seeded over Fc or EphrinB3 (Fig.   7E ).
Pre-treatment with anti-Eph4 promotes Schwann cell to mingle more with myelin in vivo, and reduces their interaction with blood vessels.
In vitro experiments established that EphrinB3 had a dual effect, impairing SC 18
DISCUSSION
Compelling evidences indicate that SC, whether recruited from the periphery or generated from resident progenitor cells, invade the CNS to remyelinate CNS axons after demyelination (5) (6) (7) (8) (9) , having an obvious impact on clinical recovery (1, 4 (12), our work demonstrates that this SC-BV interface extends to the CNS and is of relevance to their contribution to CNS repair.
We show that BV are a favorable substrate for exogenous SC and guide them towards demyelinating lesions. BV serve as scaffold for SC as soon as they leave the graft and along their path until arrival at the lesion. Along this path, SC are organized in chains going from one BV to another. At their arrival in the lesion, SC embedded in perivascular ECM become more randomly dispersed and this dispersal faithfully overlaps with BV expansion with time ( Fig. 1 ). This suggests that angiogenesis, a common response to demyelination and inflammation, via expansion of the vascular network and ECM increase, facilitates SC entry sites and dispersal in the lesion.
Since SC remyelination has shown to have an impact in the nerve function recovery(4), the clinical impact of angiogenesis in remyelination should not be overlooked.
While associated with BV at their arrival at the lesion at 3dpi, SC detached from BV to contact and align with the demyelinated axons at 5dpi. This change in substrate association may result from signals arising from the axons that trigger their differentiation into more mature SC as a first step to myelin repair. The absence of SC away from their narrow path of migration between the graft and lesion as well as their progressive increase in number in the lesion, point to their specific recruitment by the lesion most likely involving attractant signals yet to be defined. Although most of our observations were performed with exogenous SC, induction of demyelination in Krox20 cre Rosa YFP mice, hints that PNS-derived SC(7) triggered to enter the spinal cord by demyelination, use BV as scaffold to reach the lesion during spontaneous repair. SC are generated also from CNS progenitors in response to demyelination (8, 9) opening the possibility that these CNS progenitor-derived SC may also use BV to migrate towards more distant injured sites.
In physiological conditions, the vasculature network, consisting of endothelial cells and pericytes surrounded by ECM, is rather dynamic, and angiogenesis is activated in response to damage (54) . As part of this structure, ECM undergoes constant remodeling (55) , as also observed in MS and animal models, even before symptoms appear (56) . We show that injection of the lipid-toxic agent, LPC, in the absence of grafted SC, induced proliferation of endothelial cells in addition to expansion of the vasculature area. As BV remodeling is known to correlate with a change in ECM, we analyzed this impact in our paradigm. We found a prominent increase in FN and collagen 4 expressions, two main ECM components, which provide excellent substrates for SC migration. FN re-expression also affects directly OPC migration and differentiation and therefore, was proposed as a scaffold required to complete remyelination (57) . Likewise, FN promotes SC mobility(10) indicating that the observed changes in ECM composition could stimulate SC migration along BV.
BV also support SC migration in the injured PNS. However, in those circumstances, SC create direct contacts via protrusion with endothelial cells to migrate from one nerve stump to the other or in vitro when grown in 3D, suggesting that these protrusions constitute mechanical means to propel SC migration along BV in a tight environment (12) . Although we found SC associated with BV along their migrating route, direct contact with endothelial cells or pericytes was never observed. Instead We previously demonstrated that SC avoid and are repelled by myelin (20, 58) . Here we confirm these data and show that SC prevented to migrate directly through white matter, are somehow forced to migrate on BV. We showed previously that MAG, a CNS myelin component that prevents axonal regeneration in the CNS, is also inhibitory to SC migration and survival (20) . While MAG accounted only partially for the repulsive effect of myelin to SC, our data in the developmentally arrested SC (Krox20 null ) and those on SC expressing low levels of Krox20 (39) (41) . This lack of synergic effect suggests that the mechanism of Eph/ephrin activation in SC might be mediated by heterotypic recruitment independent of the initial receptor activation.
Ephrin signaling includes not only induced repulsion but also modulates expression of adhesion molecules (29) (30) (31) . We show that myelin-associated EphrinB3 modulates Despite the present implication of EphA4 and EphB6 receptors in SC response to myelin, and their contribution to SC migration along CNS BV, the involvement of other Eph receptors in SC migration within the CNS should not be disregarded. To mention, EphB2, also expressed by SC and able to bind myelin-associated EphrinB3, mediates SC-SC interaction through N-cadherin re-localization to organize SC chain migration in the PNS (29) . In fact, we observed SC in chains forming bridges going from one BV to another ( Fig. 1C2and F, Movie S1 ), suggesting the possible implication of EphB2 in these events.
In addition, EphA4 is involved in SC-astrocyte repulsion (28) . Although the interactions between SC and astrocytes has not been explored in this study, the 23 localization of the grafted SC in the vascular unit between the blood vessel wall and the astrocyte feet, suggests that the repulsion exerted by astrocytes can help confining SC to the perivascular space, and contribute to the mechanism of SC migration along BV. Interfering with EphA4 in SC could have altered this interaction and further allowed the grafted cells to escape from their perivascular path and mingle more with the surrounded white matter parenchyma.
In conclusion, we used multiple ex-vivo, in vivo and in vitro approaches to highlight a novel mechanism of guidance and migration of SC during the early events of CNS repair. We also provide strong evidences that the Eph/ephrin family regulates the complex interactions existing between SC myelin and blood vessels. SC encountering myelin-associated EphrinB3, retract their processes failing to mingle with white matter, and adhere preferentially to BV via activation of Integrinβ1. This dual effect, repulsing SC from CNS myelin and enhancing their attraction to basal lamina, directs their migration along CNS vasculature towards the lesion (Fig.9 ). 
Lesions
Schwann cell isolation and purification. Sciatic nerves of wild-type and Tg mice
were isolated at postnatal day 15 and purification procedure was adapted from the previously described protocol (35) . Briefly, enzymatic dissociation was performed by incubation with trypsin 0.025% and collagenase (420 U/ml) 10min at 37°C, followed by mechanical dissociation through different needle gages. After ending dissociation with fetal calf serum (FCS), SC were seeded in FN-coated flasks, and expanded in Dulbecco's modified Eagles medium, containing 10% heat-inactivated FCS serum, penicillin (100 mg/ml), streptomycin (100 U/ml), human recombinant Neudifferentiation factor ß (hrNDFß) (125 ng/ml), insulin (10 µg/ml) and forskolin (2 µg/ml).SC were purified by differential adhesion (60), obtaining a purity of 90%, and passaged no more than three times before use. Purification was controlled by immunocytochemistry for p75.For adhesion, migration and blocking receptor assays, SC were maintained in Sato serum-free medium(61) supplemented with hrNDFB (125 ng/ml), and forskolin (2 µg/ml).
iDISCO whole-mount immunofluorescence and imaging. Spinal cords were processed as described in the iDISCO protocol(62), including modifications described in the updated online protocol (https://idisco.info, December 2016). The primary antibody used was rabbit anti-RFP (1:1000, Rockland). Secondary antibodies used were donkey anti-rabbit Cy3 (1:800, Jackson Immunoresearch) and donkey antimouse IgG Cy5 (1:800, Jackson Immunoresearch) for intravascular staining. The cleared samples were imaged with a light sheet microscope (Ultramicroscope II;
LaVision Biotec).
RNA transcriptome analysis. Library preparation and Illumina sequencing were
performed at the EBENS genomic core facility. Briefly, (polyA+) mRNAs were purified from 250 ng of total RNA using oligo(dT). Libraries were prepared using the strand specific RNA-Seq library preparation TruSeq Stranded mRNA kit (Illumina). Libraries were multiplexed by 6 on 1 high-output flow cells. A 75 bp read sequencing was performed on a NextSeq 500 device (Illumina). A mean of 94 ± 9,5 million passing
Illumina quality filter reads was obtained for each of the 6 samples.
The analyses were performed using the Eoulsan pipeline(63), including read filtering, mapping, alignment filtering, read quantification, normalization and differential analysis. Before mapping, poly N read tails were trimmed, reads ≤40 bases were removed, and reads with quality mean ≤30 were discarded. Reads were then aligned against the Mus musculus genome from Ensembl version 84 using STAR (64) .
Alignments from reads matching more than once on the reference genome were removed using Java version of SamTools (65) . To compute gene expression, Mus musculus GFF3 genome annotation version 84 from Ensembl database was used. All overlapping regions between alignments and referenced gene were counted using HTSeq-count 0.5.3 (66) . The sample counts were normalized using DESeq 1.8.3 (67) .
Statistical treatments and differential analyses were also performed using DESeq Adhesion and Spreading Assays.
In vitro. Adhesion and spreading assays were performed in 24 well dishes. Silicon strips on coverslips were used to separate two coated areas of each coverslips (71) .
Surfaces were coated overnight at 37°C with recombinant EphrinB3-Fc fusion at 10 µg/mL and Fc equimolar (as control) on each side respectively; or myelin extract (100 µg/mL) and PBS buffer, as control. Before cell seeding, strips were removed and coverslips were washed carefully with PBS. 10 5 SC were seeded in serum-free Sato 27 medium to avoid proliferation, and allowed to adhere for 3h. Data were always expressed as ratio respect to the intra-coverslip control (24) .
Spinal cord frozen sections. Cryostat longitudinal sections(20µm thick)of snap frozen spinal cords were allowed to adhere to glass slides and were thawed at room temperature just before use. Then, 50.000 SC/sections were seeded and allowed to adhere overnight (16h) before fixation in 4% paraformaldehyde (5 min BV expansion. BV were identified by immunoreactivity to Glut1, a marker restricted to micro-vessels with blood-tissue barrier function. BV expansion was quantified as the Glut1 + area over a cut-off threshold of staining using ImageJ 1.49s.Glut1 + area in controls was averaged and every animal value of both groups was expressed as a ratio over this control mean. Endothelial cell proliferation was assessed taking into account only Glut1 + cells containing a Ki67 + nucleus clearly embedded within their cytoplasm, and excluding Ki67 + nuclei, closely apposed. 33 SC-BV association. SC-BV association was quantified in the intermediate zone,
at1mm from the graft edge in the direction of the lesion or in the lesion site.
GFP + /Hoechst + SC, with complete or more than half-cell size in contact with Glut1 + endothelial cells were counted as "closely associated cells" while those with only "tip" contacts or no contacts were considered as "not associated cells". Data are expressed as the percentage of total counted cells in both groups.
SC-Axon alignment. SC-BV alignment in the lesion site was quantified.
GFP + /Hoechst + SC, with complete or more than half-cell in parallel orientation and aligned closely to NF200 + axons (excluding alignment to BV), were counted as "closely associated cells" while those with only "tip" contacts or no contacts were considered as "not associated cells". Data are expressed as the percentage of total counted cells in both groups.
Statistics
The Evaluation of Glut1 + area shows a significant expansion of BV from 3dpi-7dpi, with a peak at 5dpi, which is similar to that observed in lesions of grafted animals, and no increase in Glut1 + area at the graft site. One-way ANOVA p<0.001, F(4,28)=10.96; two-tailed Mann Whitney test with PBS group: 3dpi (p=0.019); 5dpi (p=0.0005); and 7dpi (p=0.01). (J) The number of Ki67 + /Glut1 + cells increases at 1dpi preceding that Glut1 + area, and declines thereafter (one-way ANOVA p=0.007, F (4, 25) , D) The activation by phosphorylation of these receptors impairs SC adhesion to white matter and increases SC expression of Integrinβ1 promoting their adhesion to BV extracellular matrix (E). Lesions of white matter undergo the formation and/or remodeling of BV which increase expression of ECM adhesion molecules, such as FN, and further facilitate SC mobilization towards the lesion.
